Outcome measure | Clinic misoprostol (n=698) | Home misoprostol (n=823) | P value | % difference (95% CI) |
Failed abortion | ||||
Ongoing pregnancy | 2 (0.3) | 5 (0.6) | 0.463 | 0.3 (−0.3 to 1.0) |
Incomplete abortion | 3 (0.4) | 4 (0.5) | >0.99 | 0.1 (−0.6 to 0.7) |
Total | 5 (0.7) | 9 (1.1) | 0.443 | 0.4 (−0.6 to 1.3) |
Unscheduled contact | ||||
In-person attendance | 7 (1.0) | 22 (2.7) | 0.018 | 1.7 (0.3 to 3.0) |
Telephone contact | 66 (9.5) | 109 (13.2) | 0.021 | 3.8 (0.6 to 6.8) |
Total | 73 (10.5) | 131 (15.9) | 0.002 | 5.4 (2.1 to 8.8) |
Ultrasound review* | 42 (6.0) | 51 (6.2) | 0.884 | 0.2 (−2.2 to 2.6) |
Further medical management† | 3 (0.4) | 8 (1.0) | 0.214 | 0.6 (−0.3 to 1.3) |
Oral antibiotics | 11 (1.6) | 11 (1.3) | 0.697 | 0.3 (−1.5 to 1.0) |
All figures are number (%).
*Ultrasound review indicates those women for whom a clinic appointment for ultrasound was subsequently scheduled.
†Further medical management indicates those women who were treated with further mifepristone and/or misoprostol for clinically or ultrasound-visible retained products of conception.